iMetabolic Biopharma

iMetabolic Biopharma

Closed: Jul. 2023

About this raise

IMetabolic Biopharma, with a valuation of $25 million, is raising funds on StartEngine. It is an early-stage drug discovery company developing new, life-saving drugs to fight against some of today's most devastating chronic diseases. IMetabolic Biopharma technology-powered iPlatform™ pipeline removes the roadblocks that typically make drug development slow, expensive, and inefficient. Currently the company is pre-market. Urban Austin Kiernan founded the company in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,230,000. The campaign proceeds will be used for Therapeutic asset research and development, software research and development, executive compensation and working capital.

Expand

Investment Overview

Invested this round: $365,915

Deal Terms

Total Commitments

Platform
StartEngine
Start Date
12/19/2022
Close Date
07/06/2023
Min. Goal
$10,000
Max Goal
$1,230,000
Min. Investment

$250

Security Type

Convertible Note

Company Stage

Growth Stage

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$25,000,000

Discount

10%

Company & Team

Company

Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Location
Tempe, Arizona
Business Type
Growth
Company Website
Visit Website

Team

Employees
4
Prior Founder Exits?
Yes
Founder Name
Urban Kiernan
Title
CEO

Financials

 Revenue
$0
as of FY2022
 Monthly Burn
$7,876
as of FY2022
 Runway
0.6 months
as of FY2022

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-94,513

$-63,745

Summary Balance Sheet

FY 2022 FY 2021

Cash

$4,601

$64,248

Accounts Receivable

$0

$0

Total Assets

$4,601

$64,248

Short-Term Debt

$0

$0

Long-Term Debt

$161,025

$155,471

Total Liabilities

$161,025

$155,471

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$15,150,000
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
07/06/2023 StartEngine $25,000,000 $365,915 Convertible Note Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
iMetabolic Biopharma on StartEngine 2022
Platform: StartEngine
Security Type: Convertible Note
Valuation: $25,000,000

Follow company

Follow iMetabolic Biopharma on StartEngine 2022

Buy iMetabolic Biopharma's Deal Report

Warning: according to the close date for this deal, iMetabolic Biopharma may no longer be accepting investments.

iMetabolic Biopharma Deal Report

Get Kingscrowd's comprehensive report on iMetabolic Biopharma including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether iMetabolic Biopharma is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the iMetabolic Biopharma deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge